Frontage Labs Announces Expansion At Exton Facility

By

Frontage Labs is growing and has announced plans to expand its chemistry, manufacturing and controls (CMC) facility at 700 Pennsylvania Drive in Exton.

6.5.2014 Dongmei Wang
Dongmei Wang

The two-phase renovation plan will begin soon and is scheduled for completion by the end of September. The first phase will add two analytical laboratories and 8,000 square feet of office space.

Phase 2 construction of additional clinical trial manufacturing space for solid, semi-solid and sterile pharmaceutical products, packaging, labeling and distribution functions – will begin in January.

When phase 2 is finished mid-2015, the company expects to increase its CMC workforce and capacity by more than fifty percent.

“We’re excited that consistent growth over recent years is enabling us to expand capacity and service offerings,” said Dongmei Wang, senior vice president of CMC Services.

“The infrastructure improvements will allow us to meet ever-thriving client demand for product development support, while adding efficiency gains to small scale CTM production and laboratory throughput,” Wang said.

Frontage’s CMC service portfolio includes organic synthesis, formulation development, GMP analytical testing and GMP clinical trial material manufacturing, for all types of drug candidates ranging from novel, early phase projects to generic-equivalent and consumer care medications.

Over the last 10 years, Frontage developed oral solid, semi-solid, liquid and sterile dosage forms that have been evaluated in clinical research programs and commercialized in the US, EU and Asian markets by its clients.

Frontage helps biopharmaceutical organizations advance their research and development efforts with full service offerings. With a 12-year history of bioanalytical, clinical research and CMC operations, eight state-of-the art research facilities and more than 300 professionals in the US and China, Frontage has enabled biopharmaceutical and generic companies of all sizes to advance hundreds of molecules through clinical development and commercial launch in global markets.

Links: www.frontagelab.com

Connect With Your Community

Subscribe to stay informed!

"*" indicates required fields

Hidden
VT Yes
This field is for validation purposes and should be left unchanged.
Advertisement
Creative Capital logo